The EKOS™ Endovascular System is used for ultrasound-assisted, catheter-directed thrombolysis to quickly and safely dissolve pulmonary embolism (PE). Minimally invasive, EKOS™ leverages the power of targeted ultrasonic waves to thin and separate fibrin strands and accelerates lytic dispersion deeper...
This article reports on the CE mark received by EKOS's EkoSonic endovascular system, the first endovascular device approved for the treatment of pulmonary embolism (PE) in Europe. The EkoSonic was originally designed and approved to dissolve blood clots in the arms and legs. According to EKOS ...
The EKOS™ Control Unit 4.0 simplifies bilateral treatment of pulmonary embolism thanks to separate ports for managing two EKOS devices simultaneously.
A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLE II study JACC Cardiovasc Interv, 8 (10) (2015), pp. 1382-1392 View PDFView articleView in ScopusGoogle Scholar [15] ...
Ekos nabs FDA OK for its pulmonary embolism treatment device 8 July 2013 - UK specialist healthcare company BTG plc (LON:BTG) said today it had completed the acquisition of US interventional vascular firm EKOS Corporation, after receiving Hart-Scott-Rodino (HSR) clearance for the deal. BTG clo...
SINGLE CENTER EXPERIENCE WITH THE EKOS SYSTEM IN 100 CONSECUTIVE PATIENTS WITH ACUTE PULMONARY EMBOLISM WITH INTERMEDIATE HIGH RISKTemirlenk, MerveSchwacke, HaraldDho-Nagy, Eszter-AnnaBan, Erika-GyongyiActa Marisiensis. Seria Medica
TCTAP C-220 Successful PTA with EKOS Directed Thrombolysis Under ECMO Support for a 12-year old Girl with Massive Pulmonary Embolismdoi:10.1016/j.jacc.2017.03.457HsuChung-HoJournal of the American College of Cardiology
ACUTE MASSIVE PULMONARY EMBOLISM TREATED WITH RP IMPELLA AND EKOSdoi:10.1016/S0735-1097(20)33018-7Amr IdrisKarim Al-AziziMolly SzerlipJournal of the American College of Cardiology
pulmonary embolismright heart thrombusCurrently, the only widely accepted indication for interventional treatment in cases of pulmonary embolism is hemodynamic instability or cardiogenic shock. However, the presence of a right-heart thrombus along with a pulmonary embolism is a poor prognostic indicator, ...
He discusses why EKOS has a focus on the treatment of pulmonary embolism (PE). Hubert admits that the U.S. Food and Drug Administration's (FDA) longer timelines are slowing the medical device company down but the agency has been cordial and cooperative with EKOS. He offers his outlook on...